Controversial role of γδ T cells in colorectal cancer

Colorectal cancer (CRC) is the third most frequent type of cancer, and the second leading cause of cancerrelated deaths worldwide.Current treatments for patients with CRC do not substantially improve the survival and quality of life of patients with advanced CRC, thus necessitating the development of new treatment strategies.The emergence of immunotherapy has revitalized the field, showing great potential in advanced CRC treatment.Owing to the ability of tumor cells to evade the immune system through major histocompatibility complex shedding and heterogeneous and low antigen spreading, only a few patients respond to immunotherapy.γδ T cells have heterogeneous structures and functions, and their key roles in immune regulation, tumor immunosurveillance, and specific primary immune responses have increasingly been recognized.γδ T cells recognize and kill CRC cells efficiently, thus inhibiting tumor progress through various mechanisms.However, γδ T cells can potentially promote tumor development and metastasis.Thus, given this dual role in prognosis, these cells can act as either a "friend" or "foe" of CRC.In this review, we explore the characteristics of γδ T cells and their functions in CRC, highlighting their application in immunotherapy.